T Cell Receptors featuring Dr. James Allison | The Immunology Podcast

In episode 73 of the Immunology Podcast, we chat with Nobel laureate Dr. James Allison, the Regental Professor and Chair of the Department of Immunology, Olga Keith Wiess Distinguished University Chair for Cancer Research, Director of the Parker Institute for Cancer Research, Executive Director of the Immunotherapy Platform, and Director of the James P. Allison Institute at MD Anderson Cancer Center.
He talks about the hunt for the T cell receptor and working to bring CTLA-4 blockade into the clinic. He also discusses what’s next for immunotherapy, including future investigations into myeloid cells, and playing the harmonica in a band.
Roundup Papers:
4:07 | bit.ly/3Te74uD
9:31 | go.nature.com/...
21:06 | go.nature.com/...
27:07 | go.nature.com/...
35:14 Guest Interview
#Immunotherapy #JamesPAllison #NobelPrize
Subscribe today to never miss an episode!
Listen on Apple Podcasts: apple.co/3m9mZbF
Listen on Stitcher: bit.ly/2PHJ2ds
Listen on Spotify: spoti.fi/3hp6Iia
Official Website: immunologypodc...
Enjoy the other episodes in our full series playlist here: bit.ly/3GYuwmm
Find the podcast on social media!
Follow us on X: bit.ly/34LXOYq
Like us on Facebook: bit.ly/36nPEGh
Follow us on LinkedIn: bit.ly/3HY4mkZ
This podcast is brought to you by STEMCELL Technologies!
For a full list of products, as well as educational resources, visit our website: www.stemcell.com

[@joeeastwood3795]

What drug off label would be good for CLL,while on watch and wait?